Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

10.35
Delayed Data
As of Aug 23
 +0.02 / +0.19%
Today’s Change
6.47
Today|||52-Week Range
15.03
+12.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues42.9M42.9M36.5M39.0M
 
 
 
 
 
Cost of Goods Sold6.6M5.1M5.6M5.5M
 
 
 
 
 
Depreciation And Amortization283.0K129.0K249.0K244.0K
 
 
 
 
 
 
Operating ExpensesGross Income36.0M37.6M30.7M33.3M
 
 
 
 
 
General Expenses23.4M25.0M21.3M27.3M
 
 
 
 
 
Research And Development1.0M3.6M1.5M4.8M
 
 
 
 
 
Total Operating Expenses30.3M30.2M27.1M33.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income12.6M12.7M9.4M6.0M
 
 
 
 
 
Extraordinary Charge-26.0K--0.000.00
 
 
Other Expenses-281.0K-205.0K128.0K-249.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income12.6M12.7M9.8M6.0M
 
 
 
 
 
Income Taxes-587.0K-196.0K-1.9M-371.0K
 
 
 
 
 
Net Income12.0M12.5M7.9M6.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS49.9M49.4M49.6M49.9M
 
 
 
 
 
Shares To Calculate EPS Diluted52.1M51.7M52.0M52.8M
 
 
 
 
 
 
Earnings Per ShareEPS$0.23$0.24$0.15$0.12
 
 
 
 
 
EPS Diluted$0.23$0.24$0.15$0.12